BerGenBio Feed

	Est. tid*
2026-02-19	22:00	Bokslutskommuniké 2025
2025-11-19	22:00	Kvartalsrapport 2025-Q3
2025-08-20	22:00	Kvartalsrapport 2025-Q2
2025-06-26	N/A	Årsstämma
2025-05-21	-	X-dag ordinarie utdelning BGBIO 0.00 NOK
2025-05-21	-	Kvartalsrapport 2025-Q1
2025-02-26	-	Bokslutskommuniké 2024
2024-11-13	-	Kvartalsrapport 2024-Q3
2024-10-10	-	Extra Bolagsstämma 2024
2024-08-21	-	Kvartalsrapport 2024-Q2
2024-05-30	-	Split BGBIO 100:1
2024-05-29	-	Kvartalsrapport 2024-Q1
2024-05-24	-	X-dag ordinarie utdelning BGBIO 0.00 NOK
2024-05-23	-	Årsstämma
2024-02-14	-	Bokslutskommuniké 2023
2023-11-14	-	Kvartalsrapport 2023-Q3
2023-08-23	-	Kvartalsrapport 2023-Q2
2023-06-22	-	Kvartalsrapport 2023-Q1
2023-05-22	-	Årsstämma
2023-04-21	-	X-dag ordinarie utdelning BGBIO 0.00 NOK
2023-02-16	-	Bokslutskommuniké 2022
2022-11-15	-	Kvartalsrapport 2022-Q3
2022-08-23	-	Kvartalsrapport 2022-Q2
2022-05-24	-	Kvartalsrapport 2022-Q1
2022-04-29	-	X-dag ordinarie utdelning BGBIO 0.00 NOK
2022-04-28	-	Årsstämma
2022-02-16	-	Bokslutskommuniké 2021
2022-01-06	-	Extra Bolagsstämma 2022
2021-11-16	-	Kvartalsrapport 2021-Q3
2021-08-17	-	Kvartalsrapport 2021-Q2
2021-05-19	-	Kvartalsrapport 2021-Q1
2021-03-22	-	X-dag ordinarie utdelning BGBIO 0.00 NOK
2021-03-19	-	Årsstämma
2021-02-10	-	Bokslutskommuniké 2020
2020-12-09	-	Extra Bolagsstämma 2020
2020-11-17	-	Kvartalsrapport 2020-Q3
2020-08-18	-	Kvartalsrapport 2020-Q2
2020-05-19	-	Kvartalsrapport 2020-Q1
2020-03-17	-	X-dag ordinarie utdelning BGBIO 0.00 NOK
2020-03-16	-	Årsstämma
2020-02-11	-	Bokslutskommuniké 2019
2019-11-19	-	Kvartalsrapport 2019-Q3
2019-08-19	-	Kvartalsrapport 2019-Q2
2019-05-08	-	Kvartalsrapport 2019-Q1
2019-03-14	-	X-dag ordinarie utdelning BGBIO 0.00 NOK
2019-03-13	-	Årsstämma
2019-02-19	-	Bokslutskommuniké 2018
2018-11-13	-	Kvartalsrapport 2018-Q3
2018-08-21	-	Kvartalsrapport 2018-Q2
2018-05-15	-	X-dag ordinarie utdelning BGBIO 0.00 NOK
2018-05-15	-	Kvartalsrapport 2018-Q1
2018-05-14	-	Årsstämma
2018-03-09	-	Extra Bolagsstämma 2018
2018-02-13	-	Bokslutskommuniké 2017
2017-11-17	-	Kvartalsrapport 2017-Q3
2017-08-18	-	Kvartalsrapport 2017-Q2
2017-05-23	-	Kvartalsrapport 2017-Q1
2017-03-23	-	X-dag ordinarie utdelning BGBIO 0.00 NOK
2017-03-22	-	Årsstämma
2016-06-22	-	X-dag ordinarie utdelning BGBIO 0.00 NOK
2016-06-21	-	Årsstämma
2015-06-23	-	X-dag ordinarie utdelning BGBIO 0.00 NOK
2015-06-22	-	Årsstämma

Land	Norge
Lista	Oslo Bors
Sektor	Hälsovård
Industri	Bioteknik

2025-04-30 09:51:13 BGBIO: Financial calendar 1,69 NOK | -3,97% | 0,46 MNOK

2025-04-29 22:03:16 BerGenBio ASA: Board approval of 2024 Annual financial statement and Annual Report 2024 and update on financial calendar 1,69 NOK | -3,97% | 0,46 MNOK

2025-04-29 22:03:06 BerGenBio ASA: Board approval of 2024 Annual financial statement and Annual Report 2024 and update on financial calendar 1,69 NOK | -3,97% | 0,46 MNOK

2025-03-26 07:00:14 BGBIO: BerGenBio announces Nature Communications Publication of BGBC003 Ph2 data in relapsed/refractory Acute Myeloid Leukemia patients 1,83 NOK | +11,90% | 12,6 MNOK

2025-03-26 07:00:00 BerGenBio ASA: BerGenBio announces Nature Communications Publication of BGBC003 Ph2 data in relapsed/refractory Acute Myeloid Leukemia patients 1,83 NOK | +11,90% | 12,6 MNOK

2025-03-17 07:00:06 BGBIO: BerGenBio announces advancement of its strategic review 1,94 NOK | +28,58% | 6,44 MNOK

2025-03-17 07:00:00 BerGenBio ASA: BerGenBio announces advancement of its strategic review 1,94 NOK | +28,58% | 6,44 MNOK

2025-02-26 07:00:03 BGBIO: BerGenBio Fourth Quarter Results 2024 1,92 NOK | -79,41% | 27,2 MNOK

2025-02-26 07:00:00 BerGenBio ASA: BerGenBio Fourth Quarter Results 2024 1,92 NOK | -79,41% | 27,2 MNOK

2025-02-25 19:58:42 BGBIO: BerGenBio announces discontinuation of 1L STK11M NSCLC study and exploration of strategic alternatives 1,92 NOK | -79,41% | 27,2 MNOK

2025-02-25 19:58:42 BGBIO: BerGenBio avslutter 1L STK11m NSCLC-studie og vil utforske strategiske alternativer 1,92 NOK | -79,41% | 27,2 MNOK

2025-02-25 19:58:28 BerGenBio ASA: BerGenBio announces discontinuation of 1L STK11M NSCLC study and exploration of strategic alternatives 1,92 NOK | -79,41% | 27,2 MNOK

2025-02-25 19:58:28 BerGenBio ASA: BerGenBio avslutter 1L STK11m NSCLC-studie og vil utforske strategiske alternativer 1,92 NOK | -79,41% | 27,2 MNOK

2025-02-24 08:13:16 BerGenBio - Disclosure of shareholding 10,20 NOK | +13,13% | 12,8 MNOK

2025-02-18 07:00:09 BerGenBio ASA: Invitation to fourth quarter 2024 results webcast 7,58 NOK | -1,49% | 0,52 MNOK

2025-02-18 07:00:00 BerGenBio ASA: Invitation to fourth quarter 2024 results webcast 7,58 NOK | -1,49% | 0,52 MNOK

2025-01-07 07:00:17 BGBIO: BerGenBio Announces First Patient Entered Into Advanced Adenocarcinoma Lung Cancer Trial 9,24 NOK | +5,65% | 3,85 MNOK

2025-01-07 07:00:00 BerGenBio ASA: BerGenBio Announces First Patient Entered Into Advanced Adenocarcinoma Lung Cancer Trial 9,24 NOK | +5,65% | 3,85 MNOK

2024-12-13 14:33:35 BGBIO: Financial calendar 9,22 NOK | +1,87% | 1,92 MNOK

2024-11-26 08:00:10 BGBIO: BerGenBio to Present Company Update at DNB Nordic Healthcare Conference 12,54 NOK | -1,26% | 43,2 MNOK

2024-11-26 08:00:00 BerGenBio ASA: BerGenBio to Present Company Update at DNB Nordic Healthcare Conference 12,54 NOK | -1,26% | 43,2 MNOK

2024-11-20 20:31:05 BGBIO: BerGenBio Appoints Olav Hellebø as CEO 10,37 NOK | +29,37% | 18,7 MNOK

2024-11-20 20:30:54 BerGenBio ASA: BerGenBio Appoints Olav Hellebø as CEO 10,37 NOK | +29,37% | 18,7 MNOK

2024-11-13 07:00:04 BGBIO: BerGenBio Third Quarter Results 2024 6,45 NOK | -11,19% | 3,27 MNOK

2024-11-13 07:00:00 BerGenBio ASA: BerGenBio Third Quarter Results 2024 6,45 NOK | -11,19% | 3,27 MNOK

2024-11-06 07:00:13 BerGenBio ASA: Invitation to third quarter 2024 results webcast 7,22 NOK | -6,81% | 0,75 MNOK

2024-11-06 07:00:00 BerGenBio ASA: Invitation to third quarter 2024 results webcast 7,22 NOK | -6,81% | 0,75 MNOK

2024-10-10 21:31:26 BGBIO: CEO Martin Olin steps down 9,95 NOK | -9,72% | 4,48 MNOK

2024-10-10 21:31:12 BerGenBio ASA: CEO Martin Olin steps down 9,95 NOK | -9,72% | 4,48 MNOK

2024-10-10 11:07:14 BerGenBio ASA: Minutes from Extraordinary General Meeting 11,02 NOK | -3,23% | 1,67 MNOK

2024-10-10 11:07:04 BerGenBio ASA: Minutes from Extraordinary General Meeting 11,02 NOK | -3,23% | 1,67 MNOK

2024-10-07 07:00:05 BGBIO: BerGenBio Announces Safety Data from Dose Escalation Phase 1b in First Line NSCLC Patients 11,50 NOK | +15,00% | 6,72 MNOK

2024-10-07 07:00:00 BerGenBio ASA: BerGenBio Announces Safety Data from Dose Escalation Phase 1b in First Line NSCLC Patients 11,50 NOK | +15,00% | 6,72 MNOK

2024-09-19 15:00:11 BERGENBIO ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING 9,07 NOK | +1,06% | 0,42 MNOK

2024-09-19 15:00:00 BerGenBio ASA: BERGENBIO ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING 9,07 NOK | +1,06% | 0,42 MNOK

2024-09-09 15:24:41 BGBIO: BerGenBio to Present Company Update at H.C. Wainright Annual Global Investment Conference 8,97 NOK | -5,65% | 4,87 MNOK

2024-09-09 15:24:26 BerGenBio ASA: BerGenBio to Present Company Update at H.C. Wainright Annual Global Investment Conference 8,97 NOK | -5,65% | 4,87 MNOK

2024-08-21 07:00:14 BerGenBio Second Quarter Results 2024: Solid clinical and financial progress 11,04 NOK | -5,09% | 6,14 MNOK

2024-08-21 07:00:00 BerGenBio ASA: BerGenBio Second Quarter Results 2024: Solid clinical and financial progress 11,04 NOK | -5,09% | 6,14 MNOK

2024-08-20 07:00:06 BGBIO: BerGenBio Collaborates with Tempus to Potentially Accelerate Development in STK11m Non-Small Cell Lung Cancer 11,63 NOK | -0,92% | 4,57 MNOK

2024-08-20 07:00:00 BerGenBio ASA: BerGenBio Collaborates with Tempus to Potentially Accelerate Development in STK11m Non-Small Cell Lung Cancer 11,63 NOK | -0,92% | 4,57 MNOK

2024-08-15 09:57:37 BerGenBio ASA: Registration of share capital reduction 11,50 NOK | -1,52% | 1,75 MNOK

2024-08-15 09:57:31 BerGenBio ASA: Registration of share capital reduction 11,50 NOK | -1,52% | 1,75 MNOK

2024-08-13 07:00:17 BerGenBio ASA: Invitation to second quarter and half year 2024 results webcast 12,56 NOK | +9,83% | 7,95 MNOK

2024-08-13 07:00:00 BerGenBio ASA: Invitation to second quarter and half year 2024 results webcast 12,56 NOK | +9,83% | 7,95 MNOK

2024-07-29 07:00:04 BGBIO: BerGenBio Announces Selection of 2nd Dose in Phase 2a First Line STK11m Non-Small Lung Cancer Trial 13,30 NOK | +0,23% | 13,2 MNOK

2024-07-29 07:00:00 BerGenBio ASA: BerGenBio Announces Selection of 2nd Dose in Phase 2a First Line STK11m Non-Small Lung Cancer Trial 13,30 NOK | +0,23% | 13,2 MNOK

2024-06-26 17:35:12 BerGenBio ASA: Grant of share options 11,85 NOK | -3,97% | 2,17 MNOK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

BerGenBio

Kalender

Beskrivning

BerGenBio

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden